SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) was the recipient of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 624,362 shares, a decline of 38.6% from the November 30th total of 1,017,493 shares. Based on an average trading volume of 175,689 shares, the days-to-cover ratio is presently 3.6 days.
Shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) opened at $44.44 on Friday. SPDR S&P Pharmaceuticals ETF has a 12 month low of $37.16 and a 12 month high of $44.73. The company has a market cap of $401.04 and a price-to-earnings ratio of 2.81.
The business also recently announced a quarterly dividend, which was paid on Tuesday, December 26th. Investors of record on Monday, December 18th were given a dividend of $0.108 per share. The ex-dividend date was Friday, December 15th. This represents a $0.43 dividend on an annualized basis and a dividend yield of 0.97%. SPDR S&P Pharmaceuticals ETF’s payout ratio is presently 1.84%.
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.